Capstan Therapeutics
San Diego, US · Founded 2020 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JT
Justin ThackerExecutive Officer
KS
Karen SmithDirector
FP
Fabio PucciDirector
AB
Adrian BotExecutive Officer
MS
Michal SilverbergDirector
LS
Laura ShawverExecutive Officer, Director
NL
Nanna LuneborgDirector
MB
Michael BaranDirector
EC
Erez ChimovitsDirector
RF
Ramin Farzaneh-FarExecutive Officer
RJ
Rajul JainDirector
NS
Nandita ShangariDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$76.5MraisedMar 2024 · 14 investors · BiotechnologyRule 506(b)
▶$76.5MraisedMar 2024 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Justin ThackerExecutive Officer
- Karen SmithDirector
- Fabio PucciDirector
- Nandita ShangariDirector
- Adrian BotExecutive Officer
- Michal SilverbergDirector
- Laura ShawverExecutive Officer, Director
- Nanna LuneborgDirector
- Michael BaranDirector
- Erez ChimovitsDirector
- Ramin Farzaneh-FarExecutive Officer
- Rajul JainDirector
- Priya KarmaliExecutive Officer
- Athena CountouriotisDirector
- Offering amount
- $102M
- Amount sold
- $76.5M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$63MraisedMar 2024 · 9 investors · BiotechnologyRule 506(b)
▶$63MraisedMar 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michal SilverbergDirector
- Fabio PucciDirector
- Ramin Farzaneh-FarExecutive Officer
- Rajul JainDirector
- Laura ShawverExecutive Officer, Director
- Nanna LuneborgDirector
- Nandita ShangariDirector
- Karen SmithDirector
- Justin ThackerExecutive Officer
- Adrian BotExecutive Officer
- Erez ChimovitsDirector
- Priya KarmaliExecutive Officer
- Michael BaranDirector
- Athena CountouriotisDirector
- Offering amount
- $63M
- Amount sold
- $63M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$87.5MraisedMar 2024 · 21 investors · BiotechnologyRule 506(b)
▶$87.5MraisedMar 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fabio PucciDirector
- Nandita ShangariDirector
- Michal SilverbergDirector
- Erez ChimovitsDirector
- Athena CountouriotisDirector
- Rajul JainDirector
- Laura ShawverExecutive Officer, Director
- Ramin Farzaneh-FarExecutive Officer
- Justin ThackerExecutive Officer
- Michael BaranDirector
- Adrian BotExecutive Officer
- Nanna LuneborgDirector
- Priya KarmaliExecutive Officer
- Karen SmithDirector
- Offering amount
- $175M
- Amount sold
- $87.5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.